M L Jones
Overview
Explore the profile of M L Jones including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
215
Citations
2653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stirling C, Heddell-Cowie M, Jones M, Ashenden T, Sparks T
New Phytol
. 2021 Apr;
140(2):343-354.
PMID: 33862852
Whereas much is known of the short-term growth response to elevated atmospheric CO concentrations, [CO ] , there is relatively little information on how the response of native species is...
2.
Delpiano J, Pizarro L, Peddie C, Jones M, Griffin L, Collinson L
J Microsc
. 2018 Apr;
271(1):109-119.
PMID: 29698565
Integrated array tomography combines fluorescence and electron imaging of ultrathin sections in one microscope, and enables accurate high-resolution correlation of fluorescent proteins to cell organelles and membranes. Large numbers of...
3.
Jones M, Gibbons P, Roussel A, Dominguez B
J Vet Intern Med
. 2017 May;
31(4):1202-1208.
PMID: 28556535
Background: Knowledge of the mineral composition of the causative urolith is important to develop preventative strategies. Advances in analytic techniques have led to detection of urolith components not previously recognized....
4.
Jumars P, Thistle D, Jones M
Oecologia
. 2017 Mar;
28(2):109-123.
PMID: 28309009
Cliff and Ord (1973) made versatile methods available for the direct utilization of location data in the analysis of dispersion patterns, but their monograph has as yet seen little use...
5.
Tomaro-Duchesneau C, Saha S, Malhotra M, Jones M, Rodes L, Prakash S
Benef Microbes
. 2015 Sep;
6(6):861-9.
PMID: 26322545
Cardiovascular and coronary artery disease risk are correlated with cholesterol levels and are significant health concerns. Current cholesterol-lowering approaches includes lifestyle and diet modifications, as well as statins which presents...
6.
Seldon T, Pryor R, Palkova A, Jones M, Verma N, Findova M, et al.
Leukemia
. 2015 Aug;
30(3):692-700.
PMID: 26286117
Current immunosuppressive/anti-inflammatory agents target the responding effector arm of the immune response and their nonspecific action increases the risk of infection and malignancy. These effects impact on their use in...
7.
Champagne C, Raymond Y, Guertin N, Martoni C, Jones M, Mainville I, et al.
Benef Microbes
. 2015 Jun;
6(5):753-63.
PMID: 26036146
The goal of this study was to assess the interaction between microencapsulation and a yogurt food matrix on the survival of Lactobacillus reuteri NCIMB 30242 in four different in vitro...
8.
Leo V, Morgan N, Bem D, Jones M, Lowe G, Lordkipanidze M, et al.
J Thromb Haemost
. 2015 Jan;
13(4):643-50.
PMID: 25556537
Background: Inherited platelet function disorders (PFDs) are heterogeneous, and identification of the underlying genetic defects is difficult when based solely on phenotypic and clinical features of the patient. Objective: To...
9.
Nisar S, Jones M, Cunningham M, Mumford A, Mundell S
Br J Pharmacol
. 2014 Sep;
172(13):3242-53.
PMID: 25231155
Platelet-expressed GPCRs are critical regulators of platelet function. Pharmacological blockade of these receptors forms a powerful therapeutic tool in the treatment and prevention of arterial thrombosis associated with coronary atherosclerosis...
10.
Norman J, Westbury S, Jones M, Mumford A
Int J Lab Hematol
. 2014 Apr;
36(3):326-33.
PMID: 24750679
Heritable platelet function disorders (HPFD) are a heterogeneous group of bleeding disorders with diverse clinical and laboratory characteristics. In contrast to the severe phenotype disorders, Glanzmann thrombasthenia and Bernard-Soulier syndrome,...